No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
CA-125 Antigen / blood
-
Chemotherapy, Adjuvant
-
Female
-
Genes, BRCA1
-
Genes, BRCA2
-
Germ-Line Mutation
-
Humans
-
Neoplasm Recurrence, Local / drug therapy
-
Ovarian Neoplasms / diagnosis
-
Ovarian Neoplasms / drug therapy*
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / surgery*
-
Ovary / pathology
-
Postoperative Care
-
Risk Factors
Substances
-
Antineoplastic Agents
-
CA-125 Antigen